US Stock MarketDetailed Quotes

XRTX XORTX Therapeutics

Watchlist
  • 2.4999
  • +0.1499+6.38%
Close May 17 16:00 ET
7.26MMarket Cap-2293P/E (TTM)

XORTX Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.25%6.05M
-63.02%983.67K
-33.75%1.39M
-33.56%1.76M
-33.68%1.91M
253.56%10.29M
102.94%2.66M
562.59%2.1M
279.89%2.65M
371.19%2.88M
Selling and administrative expenses
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
547.72%482.37K
22.28%727.29K
61.59%679.61K
-General and administrative expense
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
547.72%482.37K
22.28%727.29K
61.59%679.61K
Research and development costs
-64.23%2.42M
-92.95%134.13K
-61.32%569.71K
-54.19%667.91K
-45.69%1.05M
897.94%6.76M
449.11%1.9M
391.84%1.47M
6,742.20%1.46M
17,550.46%1.93M
Depreciation amortization depletion
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
521.62%22.06K
176.62%9.76K
12.31%3.78K
-Depreciation and amortization
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
521.62%22.06K
176.62%9.76K
12.31%3.78K
Other operating expenses
17.55%1.26M
51.59%340.34K
135.93%297.02K
-25.63%339.47K
6.84%283.03K
77.87%1.07M
-2.63%224.51K
3.07%125.9K
482.55%456.45K
50.95%264.91K
Operating profit
41.25%-6.05M
63.02%-983.67K
33.75%-1.39M
33.56%-1.76M
33.68%-1.91M
-253.56%-10.29M
-102.94%-2.66M
-562.59%-2.1M
-279.89%-2.65M
-371.19%-2.88M
Net non-operating interest income expense
144.76%253.54K
-7.26%49.82K
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
2,427.32%103.59K
4,018.84%53.72K
3,372.81%35.46K
2,293.46%11.76K
277.67%2.65K
Non-operating interest income
----
----
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
----
----
--35.46K
--11.76K
--2.65K
Total other finance cost
-144.76%-253.54K
----
----
----
----
-2,427.32%-103.59K
----
----
----
----
Other net income (expense)
47.25%3.63M
13,367.34%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
84.77%2.47M
-99.67%26.98K
113.97%870.55K
168.21%1.4M
115.28%169.64K
Gain on sale of security
7.06%3.63M
281.05%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
29.37%3.39M
-89.91%953.43K
113.97%870.55K
168.21%1.4M
115.28%169.64K
Special income (charges)
--0
----
----
----
----
28.08%-926.46K
----
----
----
----
-Less:Restructuring and merger&acquisition
--0
----
----
----
----
-28.08%926.46K
----
----
----
----
Income before tax
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
-603.18%-1.24M
-57.02%-2.7M
Income tax
Net income
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
-603.18%-1.24M
-57.02%-2.7M
Net income continuous Operations
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
-603.18%-1.24M
-57.02%-2.7M
Minority interest income
Net income attributable to the parent company
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
-603.18%-1.24M
-57.02%-2.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
-603.18%-1.24M
-57.02%-2.7M
Basic earnings per share
79.12%-1.09
181.90%1.3598
19.28%-0.6699
0.00%-0.81
47.62%-0.99
-262.50%-5.22
-123.87%-1.6604
86.78%-0.8299
-457.97%-0.81
-1.95%-1.89
Diluted earnings per share
79.12%-1.09
181.90%1.3598
19.28%-0.6699
0.00%-0.81
47.62%-0.99
-262.50%-5.22
-123.87%-1.6604
86.78%-0.8299
-457.97%-0.81
-1.95%-1.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -41.25%6.05M-63.02%983.67K-33.75%1.39M-33.56%1.76M-33.68%1.91M253.56%10.29M102.94%2.66M562.59%2.1M279.89%2.65M371.19%2.88M
Selling and administrative expenses -7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K547.72%482.37K22.28%727.29K61.59%679.61K
-General and administrative expense -7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K547.72%482.37K22.28%727.29K61.59%679.61K
Research and development costs -64.23%2.42M-92.95%134.13K-61.32%569.71K-54.19%667.91K-45.69%1.05M897.94%6.76M449.11%1.9M391.84%1.47M6,742.20%1.46M17,550.46%1.93M
Depreciation amortization depletion 140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K521.62%22.06K176.62%9.76K12.31%3.78K
-Depreciation and amortization 140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K521.62%22.06K176.62%9.76K12.31%3.78K
Other operating expenses 17.55%1.26M51.59%340.34K135.93%297.02K-25.63%339.47K6.84%283.03K77.87%1.07M-2.63%224.51K3.07%125.9K482.55%456.45K50.95%264.91K
Operating profit 41.25%-6.05M63.02%-983.67K33.75%-1.39M33.56%-1.76M33.68%-1.91M-253.56%-10.29M-102.94%-2.66M-562.59%-2.1M-279.89%-2.65M-371.19%-2.88M
Net non-operating interest income expense 144.76%253.54K-7.26%49.82K79.40%63.61K523.19%73.31K2,421.78%66.8K2,427.32%103.59K4,018.84%53.72K3,372.81%35.46K2,293.46%11.76K277.67%2.65K
Non-operating interest income --------79.40%63.61K523.19%73.31K2,421.78%66.8K----------35.46K--11.76K--2.65K
Total other finance cost -144.76%-253.54K-----------------2,427.32%-103.59K----------------
Other net income (expense) 47.25%3.63M13,367.34%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K84.77%2.47M-99.67%26.98K113.97%870.55K168.21%1.4M115.28%169.64K
Gain on sale of security 7.06%3.63M281.05%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K29.37%3.39M-89.91%953.43K113.97%870.55K168.21%1.4M115.28%169.64K
Special income (charges) --0----------------28.08%-926.46K----------------
-Less:Restructuring and merger&acquisition --0-----------------28.08%926.46K----------------
Income before tax 72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M-603.18%-1.24M-57.02%-2.7M
Income tax
Net income 72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M-603.18%-1.24M-57.02%-2.7M
Net income continuous Operations 72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M-603.18%-1.24M-57.02%-2.7M
Minority interest income
Net income attributable to the parent company 72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M-603.18%-1.24M-57.02%-2.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M-603.18%-1.24M-57.02%-2.7M
Basic earnings per share 79.12%-1.09181.90%1.359819.28%-0.66990.00%-0.8147.62%-0.99-262.50%-5.22-123.87%-1.660486.78%-0.8299-457.97%-0.81-1.95%-1.89
Diluted earnings per share 79.12%-1.09181.90%1.359819.28%-0.66990.00%-0.8147.62%-0.99-262.50%-5.22-123.87%-1.660486.78%-0.8299-457.97%-0.81-1.95%-1.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg